|
MEDRAD is a worldwide market leading manufacturer and distributor of high tech medical devices that enable or enhance diagnostic and therapeutic medical procedures for computed tomography, magnetic resonance, and cardiovascular applications. |
|
XDS™ Extravasation Detector for Stellant® CT Injection Systems The XDS Extravasation Detector is designed to directly detect mild extravasations during CT injection and immediately stop the injection. This safety accessory for the Stellant CT Injection System prevents mild extravasations from becoming moderate extravasations or severe extravasations. Patented Extravasation Detection Technology XDS uses patented RF wave technology and a physical property called permittivity to detect pooling fluid under a patient's skin. This technology enables quick and highly accurate detection of extravasated fluid at less than 20mL, but typically between 5mL and 11mL. It also minimizes false positive detections common with the use of technology that relies on skin impedance. Fully Integrated and Easy-to-Use The XDS fully integrates with MEDRAD's Stellant CT Injection System. - Easy to set up and use
- Sterile disposables allow easy, consistent sensor positioning
- MEDRAD exclusive HandiSTRIPS™ easily secure disposables and sensors
Enhanced Patient Safety XDS complements the design of Stellant with features that promote confidence. - XDS sensors do not interfere with proper palpation
- Self-test feature verifies correct operation prior to use with patient
- Optimized extravasation detection with baseline established for every patient
|
|
|
|
|
|